Free Cytel E-book – The Fundamentals of Real World Evidence in Oncology Drug Development

March 18, 2022

As real-world evidence (RWE) is increasingly utilized for drug pricing and reimbursement decision, the potential for RWE to drive drug development and clinical trials in oncology is yet to be fully realized. In a new free e-book from Cytel, learn about how RWE can be implemented at every stage of clinical development to benefit patients, manufacturers, providers, and more.

According to the e-book, “Building successful regulatory and HTA submissions requires that clients understand and articulate the patient journey, burden of illness and unmet clinical and population needs. The ability to understand such need from the clinician and patient perspective can make a major difference in the favorability of an HTA body assessment. Furthermore, keen understanding of the nuances and expected outcomes within an oncology population, can augment the impact of a value dossier.”

Click here to learn more and download your free copy.

(Source: Cytel, March 18th, 2022)

Share This Story!